verified SJR 1,661 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

United States · Wiley-Blackwell

workspace_premium Q1 — Medicine (miscellaneous) visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Cancer Science

Cancer Science is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 173. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2025 €. The scope of the journal is focused on oncology, cancer research, palliative care, radiotherapy. It has an SJR impact factor of 1,661 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,661.

Cancer Science focuses its scope in these topics and keywords: growth, cancer, factor, patients, immune, cells, epidermal, signaling, targets, tumor, ...

ISSN: 1347-9032

Publisher: Wiley-Blackwell

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,661 Q1

H-index 173

Acceptance rate pie_chart

21% Selective

Source Acceptance_Rate

Time to publication hourglass_top

17 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

2.025 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

1,661

H-index

173

Docs (year)

337

Docs 3y

1192

Total refs

14486

Cites 3y

5814

Citable 3y

1179

Cites/Doc 2y

4.39

Ref/Doc

42.99

Immediate OA

2025 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Contribution of autophagic cell death to p53-dependent cell death in human glioblastoma cell line SF126

X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility

Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis

Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia

Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4

Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma

Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity

Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export

Development of a risk prediction model for lung cancer: The Japan Public Health Center-based Prospective Study

Development of a mouse model for lymph node metastasis with endometrial cancer

Deficiency of the Erc/mesothelin gene ameliorates renal carcinogenesis in Tsc2 knockout mice

Decrease of hepatic stellate cells in rats with enhanced sensitivity to clofibrate-induced hepatocarcinogenesis

SHOW MORE ARTICLES

Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma

A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells

Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-beta receptor inhibitor on extravasation of nanoparticles from neovasculature

Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells

Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients

Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line

c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo

Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics

Body iron stores and breast cancer risk in female atomic bomb survivors

Antibody epitope peptides as potential inducers of IgG antibodies against CD98 oncoprotein

Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm

Adult T-cell leukemia cells are characterized by abnormalities ofHeliosexpression that promote T cell growth

FAQs

Cancer Science has an SJR of 1,661 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2025 EUR.

The acceptance rate recorded for Cancer Science is 21%.

Cancer Science

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Science?

What is the APC / publication cost?

What is the acceptance rate?